Ryan Weight, DO discusses takeaways from the Immuno-Oncology Institute Working Group Summit. The summit was a part of the Association of Community Cancer Centers’ Immuno-Oncology Institute and brought together multidisciplinary working groups to strategize policy and delivery changes for the effective use of immunotherapy.
Ryan Weight, DO, an assistant professor of medicine, University of Colorado Health Cancer Center, discusses takeaways from the 2018 Immuno-Oncology Institute Working Group Summit. The summit was a part of the Association of Community Cancer Centers’ Immuno-Oncology Institute and brought together multidisciplinary working groups to strategize policy and delivery changes for the effective use of immunotherapy. Weight shares knowledge around the 4 working groups of physicians, nurses, mid-level providers, and healthcare administrators who aim to understand and address the issues related to immuno-oncology (IO) care.
Within 2 of the working groups at the summit, the participants discussed the role of big data and telemedicine in IO. Another working group focused on care, education, and coordination. The fourth working group examined the role of multispecialty care in IO.
SELECT Trial Establishes Lenvatinib’s Role in RAI-Refractory DTC
May 2nd 2024In an interview with Targeted Oncology, Lori J. Wirth, MD, delved into how the data from SELECT signals lenvatinib effectiveness as a frontline therapy for patients with RAI-refractory differentiated thyroid cancer.
Read More